Cerner finds a treasure in data mining - Washington Business Journal:

boyanebyboqasavo.blogspot.com
The North Kansas City-based healthg care informationtechnology company, known mostlg for the health-record software sold to hospitals and is leveraging the billions of anonymous patienyt records it has at its disposal as marketabl information to pharmaceutical companies and Cerner said the data operation is a big reasohn revenue for its LifeSciences Group has increasex by roughly 20 percen t during each of the past five years. Mark the company’s life sciences solutionws vice president, predicted that annualp growth will be greaterr still inthe future. “This is just the beginningb for us in thelife sciences,” he said. Includec in Cerner’s data warehouse are 1.
2 billioh lab results. It also has smaller numbers of medicatiohn orders and other The company collects the informationthrough data-sharing agreements with roughly 125 of its software clients. By some estimates, it can take as long as 17 yearzsand $1.2 billion to develop a singlre drug. Cerner’s data-mining capabilities can quickenh that process and save moneu for drug companies by helping the companiexs establish a study protocol that maximizes the number of eligible candidatees fora trial. “Wr believe that can actually eventually reduce the cost ofdrug development,” Hoffmaj said. Cerner would not name its pharmaceutical customers.
Pharmaceuticaol companies and clinical researchers pay for Cerner data forother reasons, said Scottg Weir, director of the ’s Office of Therapeutics Discovery and Development. He said Cerner’s data-mining capabilituy can point scientists to potentiakl new uses forexisting drugs. For instance, Weir Cerner’s database might suggest that a drug used to treat cardiovasculard disease could be helpful in treating cancer Researchers then could run a clinicapl trial to test the The data is useful to drug companies for much the same Weir said, including helping them identif and correct side effects from The KU Cancer Center has used Cerner’se data-mining capabilities for several “They uncover information we woulde never discover,” Weir said.
“It’s He said Cerner stands to benefit financially, as from collaborations with researchers that can lead to intellectuakl property that produces licensing fees and Cerner also can work with researchers suchas Dr. Stepheh Spielberg, director of the Center for Personalizex Medicine and Therapeutic Innovationat . Spielbery seeks a $3.9 million granft from the for a study of how the center can better capture data in pediatric cancerf studies usingCerner software.